TD Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

TD Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$264K	Hold	1,065	–	–	0.02%	125
2026 Q1	$214K	Hold	1,065	–	–	0.02%	130
2025 Q4	$220K	Hold	1,065	–	–	0.02%	125
2025 Q3	$191K	Sell	1,065 -83	-7%	-$14.1K	0.02%	127
2025 Q2	$185K	Hold	1,148	–	–	0.02%	126
2025 Q1	$195K	Hold	1,148	–	–	0.02%	112
2024 Q4	$191K	Buy	1,148 +1	+0.1%	+$171	0.02%	110
2024 Q3	$197K	Buy	1,147 +6	+0.5%	+$993	0.02%	111
2024 Q2	$176K	Buy	1,141 +69	+6%	+$10.4K	0.02%	110
2024 Q1	$165K	Buy	1,072 +727	+211%	+$111K	0.02%	116
2023 Q4	$54.5K	Hold	345	–	–	0.01%	173
2023 Q3	$50.5K	Buy	345 +249	+259%	+$37.9K	0.01%	170
2023 Q2	$14.7K	Buy	96 +46	+92%	+$7.17K	﹤0.01%	254
2023 Q1	$7.75K	Hold	50	–	–	﹤0.01%	285
2022 Q4	$7.71K	Hold	50	–	–	﹤0.01%	264
2022 Q3	$7K	Buy	+50	New	+$7.02K	﹤0.01%	255

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

TD Capital Management's FBT Position: Q2 2026 in Review

TD Capital Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 1,065 shares worth $264K. The position accounts for 0.02% of the portfolio, ranked #125.

TD Capital Management first reported a position in FBT in Q3 2022 and has held it in 16 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

TD Capital Management held 1,065 shares of First Trust NYSE Arca Biotechnology Index Fund worth $264K as of Q2 2026.
TD Capital Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of TD Capital Management's portfolio in Q2 2026, its #125 holding.
TD Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2022 and has held it in 16 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on TD Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.